Ranbaxy Laboratories Limited

🇨🇷Costa Rica

Country: 🇨🇷Costa Rica

Ownership: -

Established: 1996-08-30

Employees: -

Market Cap: -

Website

Clinical Trials

Bioequivalence Study of Nitrofurantoin 100 mg Capsules Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Nitrofurantoin 100 mg capsules

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 40

Registration Number: NCT00778583

Locations: 🇮🇳
Ranbaxy Research Laboratories, Gurgaon, Haryana, India

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: cefprozil 500mg tablets

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 26

Registration Number: NCT00778245

Locations: 🇨🇦
MDS Pharma Services, Montreal, Quebec, Canada

Bioequivalence Study of Loperamide Hydrochloride 2 mg and Simethicone 125 mg Tablet Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Loperamide HCl 2 mg and simethicone 125 mg tablets

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 26

Registration Number: NCT00778115

Locations: 🇺🇸
Gateway Medical Research, Inc., St. Charles, Missouri, United States

Bioequivalence Study of Gabapentin 800 mg Tablets Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Gabapentin tablets 800 mg

First Posted Date: 2008-10-23

Last Posted Date: 2008-10-23

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 22

Registration Number: NCT00778232

Locations: 🇺🇸
PRACS Institute Ltd., Fargo, North Dakota, United States

Bioequivalecne Study of Minocycline 100mg Tablets Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Minocycline 100mg Tablets

First Posted Date: 2008-10-22

Last Posted Date: 2008-10-22

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 24

Registration Number: NCT00777413

Locations: 🇺🇸
AII pharma, Chapell Hill, North Carolina, United States

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: loratadine 10 mg orally disintegrating tablets

First Posted Date: 2008-10-21

Last Posted Date: 2008-10-21

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 80

Registration Number: NCT00776217

Bioequivalence Study of Fosinopril 40mg Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Fosinopril 40mg Tablets

First Posted Date: 2008-10-21

Last Posted Date: 2008-10-21

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 40

Registration Number: NCT00776334

Locations: 🇺🇸
Gateway Medical Research Inc., St.charles, Missouri, United States

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Glimepiride 1mg Tablets

First Posted Date: 2008-10-21

Last Posted Date: 2008-10-21

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 32

Registration Number: NCT00776620

Locations: 🇺🇸
Novum Pharmaceutical Research Services, Houston, Texas, United States

Bioequivalence Study of Fosinopril 40mg Tablets Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Fosinopril 40mg Tablets

First Posted Date: 2008-10-21

Last Posted Date: 2008-10-21

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 24

Registration Number: NCT00776672

Locations: 🇺🇸
Gateway Medical Research Inc., St.charles, Missouri, United States

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: hydrochlorothiazide 50 mg tablet

First Posted Date: 2008-10-21

Last Posted Date: 2008-10-21

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 36

Registration Number: NCT00776646

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy